Skip to search formSkip to main contentSkip to account menu

barusiban

Known as: C4.6,S1-Cyclo(N-(3-sulfanylpropanoyl)-D-tryptophyl-L-isoleucyl-L-alloisoleucyl-L-asparaginyl-L-2-aminobutanoyl-N-methyl-L-ornithinol) 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Oligopeptides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Design of Oxytocin Analogs.
The neurohypophyseal hormone oxytocin (OT) and related modulators of the oxytocin receptor (OTR) have been the subject of… 
2019
2019
A randomized, double-blind, placebo-controlled, multi-center, phase 2 trial to investigate the effect of barusiban on implantation in IVF/ICSI patients
2014
2014
Late preterm birth is associated with short‐term morbidity but not with adverse neurodevelopmental and physical outcomes at 1 year
We compared the neonatal and infant outcomes at one year (Bayley mental and psychomotor development index, and physical growth… 
2013
2013
Barusiban injection and preparation method thereof
The invention relates to the technical field of medicine and discloses a barusiban injection and a preparation method thereof… 
2012
2012
Effects of barusiban, a selective oxytocin antagonist, on uterine contractility in the luteal phase after controlled ovarian stimulation
2009
2009
The effect of barusiban, a selective oxytocin antagonist, in threatened preterm labor at late gestational age: a randomized, double-blind, placebo-controlled trial.
2007
2007
Barusiban suppresses oxytocin-induced preterm labour in non-human primates
Background Preterm labour (PTL) is a major cause of neonatal mortality and morbidity, and oxytocin (OT) antagonists are potential… 
2006
2006
Barusiban, An Effective Long-Term Treatment of Oxytocin-Induced Preterm Labor in Nonhuman Primates1
Abstract Preterm labor (PTL) affects up to 25% of human pregnancies in developing countries, but there are few therapeutic… 
2005
2005
Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)